Zoetis Inc. (ZTS)
NYSE: ZTS · IEX Real-Time Price · USD
169.56
+0.12 (0.07%)
May 31, 2024, 4:00 PM EDT - Market closed
Zoetis Revenue
Zoetis had revenue of $8.73B in the twelve months ending March 31, 2024, with 7.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.19B with 9.50% year-over-year growth. In the year 2023, Zoetis had annual revenue of $8.54B with 5.74% growth.
Revenue (ttm)
$8.73B
Revenue Growth
+7.91%
P/S Ratio
8.86
Revenue / Employee
$619,433
Employees
14,100
Market Cap
77.37B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.54B | 464.00M | 5.74% |
Dec 31, 2022 | 8.08B | 304.00M | 3.91% |
Dec 31, 2021 | 7.78B | 1.10B | 16.49% |
Dec 31, 2020 | 6.68B | 415.00M | 6.63% |
Dec 31, 2019 | 6.26B | 435.00M | 7.47% |
Dec 31, 2018 | 5.83B | 518.00M | 9.76% |
Dec 31, 2017 | 5.31B | 419.00M | 8.57% |
Dec 31, 2016 | 4.89B | 123.00M | 2.58% |
Dec 31, 2015 | 4.77B | -20.00M | -0.42% |
Dec 31, 2014 | 4.79B | 224.00M | 4.91% |
Dec 31, 2013 | 4.56B | 225.00M | 5.19% |
Dec 31, 2012 | 4.34B | 103.00M | 2.43% |
Dec 31, 2011 | 4.23B | 651.00M | 18.17% |
Dec 31, 2010 | 3.58B | 822.00M | 29.78% |
Dec 31, 2009 | 2.76B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CVS Health | 360.94B |
McKesson | 308.95B |
Cigna | 206.00B |
HCA Healthcare | 66.72B |
Bristol-Myers Squibb Company | 45.53B |
GSK | 39.41B |
Gilead Sciences | 27.45B |
Becton, Dickinson and Company | 19.72B |
ZTS News
- 13 hours ago - IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTS - PRNewsWire
- 1 day ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 9 days ago - Zoetis Declares Third Quarter 2024 Dividend - Business Wire
- 10 days ago - Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference - Business Wire
- 12 days ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 14 days ago - IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 15 days ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire